185 related articles for article (PubMed ID: 22840351)
21. Salvage focal and salvage total cryoablation for locally recurrent prostate cancer after primary radiation therapy.
de Castro Abreu AL; Bahn D; Leslie S; Shoji S; Silverman P; Desai MM; Gill IS; Ukimura O
BJU Int; 2013 Aug; 112(3):298-307. PubMed ID: 23826840
[TBL] [Abstract][Full Text] [Related]
22. Functional and oncological outcomes of salvage cryosurgery for radiorecurrent prostate cancer.
Exterkate L; Peters M; Somford DM; Vergunst H
BJU Int; 2021 Jul; 128(1):46-56. PubMed ID: 33043572
[TBL] [Abstract][Full Text] [Related]
23. Prostate gland lengths and iceball dimensions predict micturition functional outcome following salvage prostate cryotherapy in men with radiation recurrent prostate cancer.
Ahmad I; Kalna G; Ismail M; Birrell F; Asterling S; McCartney E; Greene D; Davies J; Leung HY
PLoS One; 2013; 8(8):e69243. PubMed ID: 23950886
[TBL] [Abstract][Full Text] [Related]
24. Prostate-specific antigen after salvage radiotherapy for postprostatectomy biochemical recurrence predicts long-term outcome including overall survival.
Bartkowiak D; Thamm R; Bottke D; Siegmann A; Böhmer D; Budach V; Wiegel T
Acta Oncol; 2018 Mar; 57(3):362-367. PubMed ID: 28816074
[TBL] [Abstract][Full Text] [Related]
25. Prognostic factors in postoperative radiotherapy for prostate cancer - tertiary center experience.
Miszczyk M; Majewski W; Stawiski K; Rasławski K; Rajwa P; Jabłońska I; Magrowski Ł; Masri O; Paradysz A; Miszczyk L
Radiol Oncol; 2021 Mar; 55(2):203-211. PubMed ID: 33768769
[TBL] [Abstract][Full Text] [Related]
26. Predictors of prostate-specific antigen biochemical recurrence in patients undergoing primary whole-gland prostate cryoablation.
Liu YY; Chiang PH; Chuang YC; Lee WC; Cheng YT; Wang HJ
Ann Surg Oncol; 2015 May; 22(5):1612-7. PubMed ID: 25287436
[TBL] [Abstract][Full Text] [Related]
27. Biochemical recurrence after robot-assisted radical prostatectomy in a European single-centre cohort with a minimum follow-up time of 5 years.
Sooriakumaran P; Haendler L; Nyberg T; Gronberg H; Nilsson A; Carlsson S; Hosseini A; Adding C; Jonsson M; Ploumidis A; Egevad L; Steineck G; Wiklund P
Eur Urol; 2012 Nov; 62(5):768-74. PubMed ID: 22633365
[TBL] [Abstract][Full Text] [Related]
28. Long-term Outcome of Prostate Cancer Patients Who Exhibit Biochemical Failure Despite Salvage Radiation Therapy After Radical Prostatectomy.
Ying J; Wang CJ; Yan J; Liauw SL; Straka C; Pistenmaa D; Xie XJ; Lotan Y; Roehrborn C; Kim DN
Am J Clin Oncol; 2017 Dec; 40(6):612-620. PubMed ID: 26165416
[TBL] [Abstract][Full Text] [Related]
29. Predictors of biochemical failure in patients undergoing prostate whole-gland salvage cryotherapy: a novel risk stratification model.
Spiess PE; Levy DA; Mouraviev V; Pisters LL; Jones JS
BJU Int; 2013 Aug; 112(4):E256-61. PubMed ID: 23469778
[TBL] [Abstract][Full Text] [Related]
30. Is cryosurgery a feasible local therapy for bone metastatic prostate cancer?
Sheng M; Wan L; Liu C; Liu C
Singapore Med J; 2018 Nov; 59(11):584-589. PubMed ID: 30246213
[TBL] [Abstract][Full Text] [Related]
31. Long-Term Outcomes of Whole Gland Salvage Cryotherapy for Locally Recurrent Prostate Cancer following Radiation Therapy: A Combined Analysis of Two Centers.
Chin JL; Lavi A; Metcalfe MJ; Siddiqui K; Dewar M; Petros FG; Li R; Nogueras González GM; Wang X; Nair SM; Ward JF; Pisters L
J Urol; 2021 Sep; 206(3):646-654. PubMed ID: 33908799
[TBL] [Abstract][Full Text] [Related]
32. Three-year postoperative ultrasensitive prostate-specific antigen following open radical retropubic prostatectomy is a predictor for delayed biochemical recurrence.
Malik RD; Goldberg JD; Hochman T; Lepor H
Eur Urol; 2011 Sep; 60(3):548-53. PubMed ID: 21652145
[TBL] [Abstract][Full Text] [Related]
33. Predictors of biochemical recurrence after primary focal cryosurgery (hemiablation) for localized prostate cancer: A multi-institutional analytic comparison of Phoenix and Stuttgart criteria.
Kongnyuy M; Lipsky MJ; Islam S; Robins DJ; Hager S; Halpern DM; Kosinski KE; Schiff JT; Corcoran AT; Wenske S; Katz AE
Urol Oncol; 2017 Aug; 35(8):530.e15-530.e19. PubMed ID: 28410986
[TBL] [Abstract][Full Text] [Related]
34. Stage T1-2 prostate cancer: a multivariate analysis of factors affecting biochemical and clinical failures after radical prostatectomy.
Kupelian PA; Katcher J; Levin HS; Klein EA
Int J Radiat Oncol Biol Phys; 1997 Mar; 37(5):1043-52. PubMed ID: 9169811
[TBL] [Abstract][Full Text] [Related]
35. Retreatment for Local Recurrence of Prostatic Carcinoma After Prior Therapeutic Irradiation: Efficacy and Toxicity of HDR-Like SBRT.
Fuller D; Wurzer J; Shirazi R; Bridge S; Law J; Crabtree T; Mardirossian G
Int J Radiat Oncol Biol Phys; 2020 Feb; 106(2):291-299. PubMed ID: 31629838
[TBL] [Abstract][Full Text] [Related]
36. The PSA-response to salvage radiotherapy after radical prostatectomy correlates with freedom from progression and overall survival.
Bartkowiak D; Bottke D; Thamm R; Siegmann A; Hinkelbein W; Wiegel T
Radiother Oncol; 2016 Jan; 118(1):131-5. PubMed ID: 26653358
[TBL] [Abstract][Full Text] [Related]
37. High-intensity Focused Ultrasound (HIFU) as salvage therapy for radio-recurrent prostate cancer: predictors of disease response.
Dason S; Wong NC; Allard CB; Hoogenes J; Orovan W; Shayegan B
Int Braz J Urol; 2018; 44(2):248-257. PubMed ID: 29211405
[TBL] [Abstract][Full Text] [Related]
38. Focal cryotherapy for clinically unilateral, low-intermediate risk prostate cancer in 73 men with a median follow-up of 3.7 years.
Bahn D; de Castro Abreu AL; Gill IS; Hung AJ; Silverman P; Gross ME; Lieskovsky G; Ukimura O
Eur Urol; 2012 Jul; 62(1):55-63. PubMed ID: 22445223
[TBL] [Abstract][Full Text] [Related]
39. Prostate-Specific Antigen (PSA) Bounce After Dose-Escalated External Beam Radiation Therapy Is an Independent Predictor of PSA Recurrence, Metastasis, and Survival in Prostate Adenocarcinoma Patients.
Romesser PB; Pei X; Shi W; Zhang Z; Kollmeier M; McBride SM; Zelefsky MJ
Int J Radiat Oncol Biol Phys; 2018 Jan; 100(1):59-67. PubMed ID: 29254782
[TBL] [Abstract][Full Text] [Related]
40. Outcomes of salvage prostate cryotherapy stratified by pre-treatment PSA: update from the COLD registry.
Spiess PE; Levy DA; Pisters LL; Mouraviev V; Jones JS
World J Urol; 2013 Dec; 31(6):1321-5. PubMed ID: 23179729
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
